Stephen Boyer, BitSight's co-founder and CTO, discusses how cybersecurity remains a continued concern that can play a critical role in major deals and investments. Read more.
Jake Olcott, BitSight's vice president of communications and government affairs, discusses the rise in investment in third-party risk management and how companies have been forced to adjust their...
Jake Olcott, BitSight's vice president of communications and government affairs, discusses how security leaders can step in and do what they can to justify spending that bolsters their company's...
Jake Olcott, BitSight's vice president of communications and government affairs, discusses what healthcare providers need to be doing to reduce vulnerabilities and bolster defenses. Read more.
Recent BitSight data found flaws in 17 biomedical companies publicly recognized for playing a role in the development of a COVID-19 vaccine. Read more.
BitSight assessed 17 biomedical companies publicly recognized for playing a role in the development of a COVID-19 vaccine and found many operate with serious security vulnerabilities.
BitSight researchers shared the results of a study that looked for detectable security issues at a number of companies who play a big role in the global search for a vaccine, and found compromised...
Research from BitSight found 45% of remote office networks observed malware in March alone. Read more.
BitSight research reveals 45% of remote office networks have observed malware, compared to 13% of corporate networks. Read more.
A recent study by BitSight found home networks were seven times more likely than an office network to have five or more types of malware. Read more.
Jake Olcott, BitSight vice president of Communications and Government Affairs, discusses how temporary hospitals can lack necessary security to keep hackers from targeting them. Read more.
BitSight announced several new, innovative capabilities for Third-Party Risk Management. The enhanced platform will help organizations achieve greater operational efficiency. Read more.